±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 2315  |  »Ø¸´: 17

lgslgwlgs

ľ³æ (СÓÐÃûÆø)

[½»Á÷] ¡¾×ªÌû¡¿»ªÈË¿ÆÑ§¼Ò·¢ScienceÎÄÕ»ñÍ»ÆÆÐÔÑо¿³É¹û ÒÑÓÐ15È˲ÎÓë

»ªÈË¿ÆÑ§¼Ò·¢ScienceÎÄÕ»ñÍ»ÆÆÐÔÑо¿³É¹û


      À´×ÔNIHÃÀ¹ú¹ú¼Ò¹ýÃôÓ봫Ⱦ²¡Ñо¿Ëù(NIAID)£¬¹þ·ðҽѧԺµÈ´¦µÄÑо¿ÈËÔ±·¢ÏÖÁËÁ½ÖÖ¿É·ÀÖ¹¸÷ÖÖ°¬×̲¡²¡¶¾(HIV)¸ÐȾÓë·±Ö³µÄÖкͿ¹Ì壬ÕâЩ¿¹ÌåÄܹ»ÓëÒ»×éHIV-1·ÖÀëÖêÖеÄ90%ÒÔÉϵIJ¡¶¾Öê½áºÏ²¢ÖкÍËüÃÇ¡£ÕâÏîÖØÒªµÄÑо¿³É¹û¹«²¼ÔÚScienceÔÓÖ¾ÉÏ£¬Í¬ÆÚScienceÔÓÖ¾ÉÏÁ½ÆªÎÄÕÂÏêϸ½éÉÜÁËÕâÖÖ¿¹Ìå¡£
      ÆäÖÐһƪÎÄÕµĵÚÒ»×÷ÕßÖ®Ò»ÊÇĿǰÔÚÃÀ¹ú¹ú¼ÒÎÀÉúÑо¿ÔºÒßÃçÑо¿ÖÐÐÄ´Óʰ¬×̲¡ÒßÃçÑо¿¹¤×÷µÄÖÜͬÇ첩ʿ£¬ËûÔøÔÚNature·âÃæÉÏ·¢±íÎÄÕ£¬»ñµÃÁËÒ»¸öHIV£¨ÈËÃâÒßȱÏݲ¡¶¾£©°üĤµ°°×gp120Í»±äϵ£¬²¢È·¶¨ÁËÆäÖÐÖкͿ¹Ì壨neutralizing antibody£©b12µÄ½á¹¹£¬ÎªÒÖÖÆHIV-1°Ð¶¨ÕâÒ»ÇøÓò¿¹ÌåÒ©ÎïÑз¢ÒÔ¼°HIV»úÖÆÑо¿ÌṩÁËÍ»ÆÆÐÔµÄÑо¿³É¹û¡£
      ×Ô´ÓÈËÀà1980Äê´ú³õ·¢ÏÖ°¬×̲¡ÒÔÀ´£¬È«Çò´óÔ¼ÒÑÓÐ6000ÍòÈ˸ÐȾÁ˰¬×̲¡²¡¶¾¡£°¬×̲¡µÄÔ¤·ÀºÍÖÎÁÆÒ»Ö±ÊÇÈ«Çòҽѧ¿ÆÑ§¼ÒÂŹ¥²»¿ËµÄÄÑÌ⣬µ«ÊÇ×ÔÈ¥ÄêÒÔÀ´£¬°¬×̲¡ÒßÃçÑо¿»ñµÃÁ˳¤×ãµÄ½øÕ¹£¬±ÈÈçÈ¥Äê9Ô£¬ÃÀ¹úºÍÌ©¹úÑо¿ÈËÔ±Ðû²¼»ñµÃÊÀ½çÉϵÚÒ»ÖÖ¾ßÓÐÒ»¶¨ÃâÒßЧ¹ûµÄ°¬×̲¡ÒßÃç¡£
      ÔÚ×îеÄÕâÁ½ÆªÎÄÕÂÖУ¬Ñо¿ÈËÔ±Ôò±¨µÀÁËÁ½ÖÖÒÔǰδ֪µÄÖкͿ¹Ì壬ÕâЩ¿¹ÌåÄܹ»ÓëÒ»×éHIV-1·ÖÀëÖêÖеÄ90%ÒÔÉϵIJ¡¶¾Öê½áºÏ²¢ÖкÍËüÃÇ¡£Ñо¿ÈËÔ±ÈÏΪ¸Ã×éHIV-1·ÖÀëÖ꺭¸ÇÁËËùÓÐÖ÷ÒªµÄÕýÔÚÁ÷ÐеÄHIV-1»ùÒòÑÇÐÍ£¬ÕâЩ¿¹Ìå¿É°ïÖúÈËÃÇÔÚδÀ´Éè¼Æ³öÓÐЧµÄHIVÒßÃç¡£
      µÚһƪÎÄÕÂÖУ¬Ñо¿ÈËÔ±Ìá³ö£¬´ó¶àÊýµÄÆäËü¹ãÆ×ÖкͿ¹Ìå¶ÔHIVµÄ°üĤµ°°×¾ßÓÐÌØÒìÐÔ£¬ÕâЩµ°°×ͨ³£Óë±ê°Ðϸ°û±íÃæµÄCD4ÊÜÌå½áºÏ£¬Òò´ËÑо¿ÈËÔ±¶ÔÊܵ½¸ÐȾ¸öÌåÖеÄÓë¸ÃCD4²¿Î»½áºÏµÄ×ÔÈ»·¢ÉúµÄ¿¹Ìå½øÐÐÁËÑо¿¡£Ñо¿ÈËÔ±½Ó×Å·ÖÀë³öÁ˲úÉúÕâЩ¿¹ÌåµÄ¸öÌåBϸ°û²¢·¢ÏÖÁ˸ßÇ¿¶ÈµÄHIV-1µÄÖкͿ¹Ìå¡£
     Ñ°ÕÒ¿ÉÖкÍÖÚ¶à°¬×̲¡²¡¶¾¾úÖêµÄµ¥¸ö¿¹Ìåһֱʮ·ÖÀ§ÄÑ£¬ÕâÊÇÒòΪÕâÀಡ¶¾Äܲ»¶Ï¸Ä±ä×ÔÉí±íÃæµÄµ°°×À´¡°ÃɱΡ±ÃâÒßϵͳ£¬´Ó¶ø³É¹¦ÈëÇÖÈËÌå¡£µ«¼´Ê¹Èç´Ë£¬¿ÆÑ§¼ÒÈÔȻȷ¶¨Á˰¬×̲¡²¡¶¾±íÃæÐ¡²¿·Ö¼¸ºõ²»±äµÄÇøÓò£¬ÈçÃûΪCD4µÄ½áºÏ²¿Î»¡£VRC01ºÍVRC02¿¹Ìå¾Í¿É¸½×ÅÔÚÎȶ¨µÄCD4ÇøÓòÄÚ£¬×èÖ¹²¡¶¾¡°´îÉÏ¡±ÈËÌåÃâÒßϸ°û£¬¶øÕâÒ²½âÊÍÁË£¬ÎªÊ²Ã´´ËÁ½ÖÖп¹ÌåÄܹ»Öк͸ߴï90%µÄ°¬×̲¡²¡¶¾¾úÖê¡£
      ÁíÍâһƪÎÄÕÂÖУ¬Ñо¿ÈËÔ±·ÖÎöÁËб»·¢ÏÖ¿¹ÌåÖ®Ò»£¨VRC01£©µÄ¾§Ìå½á¹¹£¬¸Ã¿¹ÌåÕý´¦ÓÚHIV-1 °üĤµ°°×µÄÒ»¸ö¸´ºÏÎïÖС£Ñо¿ÈËÔ±ÈÏΪVRC01¿É²¿·ÖÄ£ÄâCD4 ÊÜÌåÓë¸Ã²¡¶¾°üĤµ°°×µÄÏ໥×÷Ó㬵«VRC01±¾ÉíµÄ¶¨Î»ÊǾ۽¹ÓÚÒ»¸öÔÚ²»Í¬µÄ²¡¶¾ÖêÖж¼²»»á±äµÄ²¿Î»£¬Õâ¿ÉÒÔ½âÊÍÆäΪʲô¾ßÓйãÆ×µÄÖкÍÄÜÁ¦¡£ VRC01¿¹ÌåÕýÊÇÒÔÕâÖÖ·½·¨À´ÖкͲ¡¶¾£¬²¢ÖÐ¶ÏÆäÖÂÃüÐÔÖ²¡Á¦µÄ¡£
      ¸ù¾ÝÕâЩÑо¿³É¹û£¬Ñо¿ÈËÔ±¿ÉÒÔ»ùÓÚ¶Ô²¡¶¾½á¹¹µÄ³ä·ÖÀí½â£¬ÀûÓ÷Ö×ÓÉ豸ÔÚ°¬×̲¡²¡¶¾Íâ±í¾«È·¶¨Î»²¡¶¾Ò×Êܹ¥»÷µÄλÖ㬲¢ÕÒµ½¸½×ÅÔÚÕâЩ±¡ÈõµãÉÏ¡¢¿ÉÓÐЧ×èÖ¹²¡¶¾¸ÐȾ½¡¿µÏ¸°ûµÄ¿¹Ìå¡£

Ô­ÎÄÕªÒª£º

Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
    Cross-reactive neutralizing antibodies (NAbs) are found in the sera of many HIV-1¨Cinfected subjects, but the virologic basis of their neutralization remains poorly understood. We used knowledge of HIV-1 envelope (Env) structure to develop antigenically resurfaced glycoproteins specific for the structurally conserved site of CD4 receptor binding. These probes were used to identify sera with NAbs to the CD4-binding site (CD4bs) and to isolate individual B cells from such an HIV-1¨Cinfected donor. By expressing immunoglobulin genes from individual cells, we identified three monoclonal antibodies, including a pair of somatic variants that neutralized over 90% of circulating HIV-1 isolates. Exceptionally broad HIV-1 neutralization can be achieved with individual antibodies targeted to the functionally conserved CD4bs of gp120, an important insight for future HIV-1 vaccine design.
(http://www.ebiotrade.com/)
http://www.ebiotrade.com/newsf/2010-7/2010719173036450.htm
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÙþÁÁµí·Ûø

ר¼Ò¹ËÎÊ (ÖªÃû×÷¼Ò)

ÉúÎï´ó·Ö×Ó½µ½âø

»ªÈË£¬»¹ÊÇÖйúÈËÂð£¿
Á÷ÐÇÀ´Ê±ÎÒÐíÁ˸öÔ¸£¬Ô¸ÎÒÓгÔÓкȻ¹ÓÐÊæ·þµÄÖíȦ¡£ÌÖÑá·¢Ìûǰ²»ËÑË÷ÂÛÌ³ÖØ¸´·¢ÌûºÍ½ö°ÑÂÛ̳µ±½â¾öÎÊÌ⹤¾ß£¬¾Ã²»¿´ÂÛ̳һÀ´¾ÍÌáÎÊÕߣ¬ÄþÆúEPIºÍVIPÒ²²»»ØÌû¡£
2Â¥2010-07-20 13:07:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

1949stone

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)

º£Äɰٴ¨

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
ÒýÓûØÌû:
Originally posted by ÙþÁÁµí·Ûø at 2010-07-20 13:07:10:
»ªÈË£¬»¹ÊÇÖйúÈËÂð£¿

»ªÈË ÒÔǰÊÇÖйúÈË »ò׿ÉÏÓÐÈËÊÇÖйúÈË µ«ËûÏÖÔÚ²»ÊÇÖйúÈË
º£Äɰٴ¨Ö¹ÓÚÖÁÉÆ
3Â¥2010-07-20 15:37:58
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÙþÁÁµí·Ûø

ר¼Ò¹ËÎÊ (ÖªÃû×÷¼Ò)

ÉúÎï´ó·Ö×Ó½µ½âø

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
scelab:ͬ¸Ð°¡~~~ 2010-07-20 23:43:00
Õâ¾Íû±ØÒªÕâôעÒâÁË£¬ÔÚÎÒÑÛÖÐÊÀ½çÉÏÖ»ÓÐÈýÖÖ¹ú¼®£ºÖйú£¬ÈÕ±¾ºÍÍâ¹ú£¬ËùνµÄ»ªÈ˲»ÊÇÖйúÈË£¬ÊÇÍâ¹úÈË£¬´ïµ½µÄ³É¾Í²»ÊôÓÚÖйú£¬ÖйúÈËÒÔ´ËΪÈÙÊÇ´¿´âYY¡£
Á÷ÐÇÀ´Ê±ÎÒÐíÁ˸öÔ¸£¬Ô¸ÎÒÓгÔÓкȻ¹ÓÐÊæ·þµÄÖíȦ¡£ÌÖÑá·¢Ìûǰ²»ËÑË÷ÂÛÌ³ÖØ¸´·¢ÌûºÍ½ö°ÑÂÛ̳µ±½â¾öÎÊÌ⹤¾ß£¬¾Ã²»¿´ÂÛ̳һÀ´¾ÍÌáÎÊÕߣ¬ÄþÆúEPIºÍVIPÒ²²»»ØÌû¡£
4Â¥2010-07-20 20:06:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

cnlics

ľ³æ (СÓÐÃûÆø)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
1949stone:¿ÉÒÔ˵µÃ¾ßÌåÒ»µã²» 2010-07-21 18:31:39
²»¹ÜËûÊÇÄĹúÈË£¬ËûµÄÎÄÕ¿°³ÆÒ©ÎïÉè¼ÆµÄµä·¶ÎÄÕ£¬ÖµµÃÈÏÕæ¶Á¼¸±é£¬ÄÜÔÚµçÄÔÉÏÄ£ÄâÒ»±é×îºÃ¡£
5Â¥2010-07-20 22:07:09
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

cty1984

ľ³æ (ÖøÃûдÊÖ)

СÊéͯ

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
µçÄÔÉÏÄ£Äâ?ÄǸöÈí¼þ£¿
¼á³Ö¾ÍÊÇʤÀû£¡
6Â¥2010-07-21 17:26:15
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ivyyy

Òø³æ (³õÈëÎÄ̳)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
ai£¬²»Ëµ
7Â¥2010-07-21 18:19:18
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

daijiangtao

ľ³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
ÖµµÃÎÒÃÇÉî˼°¡£¬Ôõô¹úÄÚºÜÄÑ×ö³öÕâÑùµÄ³É¼¨°¡¡£
8Â¥2010-07-21 18:23:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
9Â¥2010-07-21 18:34:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

huangshuaige

Í­³æ (СÓÐÃûÆø)

ÐÄÏëʳÉ~~
Ò»ÇÐ˳Àû
10Â¥2010-07-21 18:35:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ lgslgwlgs µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ±¾¿ÆË«·Ç²ÄÁÏ£¬¿ç¿¼Ò»Ö¾Ô¸»ªµç085801µçÆø£¬283Çóµ÷¼Á£¬ÈκÎרҵ¶¼¿ÉÒÔ +6 ֥ʿѩbaoo 2026-03-28 8/400 2026-03-29 08:16 by ËÉ»¨¸×1201
[¿¼ÑÐ] 11408Èí¼þ¹¤³ÌÇóµ÷¼Á +3 Qiuѧing 2026-03-28 3/150 2026-03-28 21:50 by zhq0425
[¿¼ÑÐ] Çóµ÷¼Á +7 ÕùÈ¡¾Åµã˯ 2026-03-28 8/400 2026-03-28 21:07 by ÕùÈ¡¾Åµã˯
[¿¼ÑÐ] 083000ѧ˶274Çóµ÷¼Á +8 LiÀîÓã 2026-03-26 8/400 2026-03-28 20:33 by ¼ÓÓÍÏòδÀ´°¡
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª±±µçÁ¦´óѧÄܶ¯×¨Ë¶£¬293£¬Çóµ÷¼Á +3 15537177284 2026-03-23 5/250 2026-03-28 16:11 by xxxsssccc
[¿¼ÑÐ] 347Çóµ÷¼Á +3 ɽ¶¥¼û¦Á 2026-03-25 3/150 2026-03-28 14:13 by ÌÆãå¶ù
[¿¼ÑÐ] 317Çóµ÷¼Á +6 Ê®ÏÐwx 2026-03-24 6/300 2026-03-28 13:27 by Iveryant
[¿¼ÑÐ] 0856£¬²ÄÁÏÓ뻯¹¤321·ÖÇóµ÷¼Á +12 ´ó²öС×Ó 2026-03-27 13/650 2026-03-28 10:56 by self2008
[¿¼ÑÐ] ²ÄÁÏ292µ÷¼Á +12 éÙËÌ˼ÃÀÈË 2026-03-23 12/600 2026-03-27 15:44 by caszguilin
[¿¼ÑÐ] 0856µ÷¼Á +5 ÇóÇóÈÃÎÒÓÐÊé¶Á° 2026-03-26 6/300 2026-03-27 15:12 by caszguilin
[¿¼ÑÐ] »¯Ñ§308·ÖÇóµ÷¼Á +8 ÄãºÃÃ÷ÌìÄãºÃ 2026-03-23 9/450 2026-03-27 14:01 by Ñî¹âÓÚÇàÔÆ
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¶«Àí¹¤´óѧ081700£¬³õÊÔ·ÖÊý271 +6 kotoko_ik 2026-03-23 7/350 2026-03-27 12:29 by »ÝÖÝÅíÓÚêÌ
[¿¼ÑÐ] 325Çóµ÷¼Á +5 Àî¼Îͼ¡¤S¡¤Â· 2026-03-23 5/250 2026-03-27 00:42 by wxiongid
[¿¼ÑÐ] ÉúÎïѧ 296 Çóµ÷¼Á +4 ¶ä¶ä- 2026-03-26 6/300 2026-03-26 19:01 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ²ÄÁÏ¿¼ÑÐÇóµ÷¼Á +3 Dendel 2026-03-23 6/300 2026-03-26 17:51 by fmesaito
[¿¼ÑÐ] ¿¼ÑÐÒ»Ö¾Ô¸ËÕÖÝ´óѧ³õʼ315£¨Ó¢Ò»£©Çóµ÷¼Á +3 sbdksD 2026-03-24 4/200 2026-03-25 18:16 by xcjcqu
[¿¼ÑÐ] 285Çóµ÷¼Á +3 AZMK 2026-03-24 3/150 2026-03-25 12:23 by userper
[¿¼ÑÐ] 293Çóµ÷¼Á +7 ¼ÓÒ»Ò»¾Å 2026-03-24 7/350 2026-03-25 12:02 by userper
[¿¼ÑÐ] »¯¹¤×¨Ë¶Çóµ÷¼Á +3 questionÍì·ç 2026-03-24 3/150 2026-03-24 18:48 by jhhcooi
[¿¼ÑÐ] 335Çóµ÷¼Á +4 yuyuÓî 2026-03-23 5/250 2026-03-23 23:49 by Txy@872106
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û